DE69810784T2 - Verwendung von xanthophyllen zur herstellung von arzneimitteln zur verbesserung der muskel-funktionsdauer oder zur behandlung von muskelstörungen oder erkrankungen - Google Patents
Verwendung von xanthophyllen zur herstellung von arzneimitteln zur verbesserung der muskel-funktionsdauer oder zur behandlung von muskelstörungen oder erkrankungenInfo
- Publication number
- DE69810784T2 DE69810784T2 DE69810784T DE69810784T DE69810784T2 DE 69810784 T2 DE69810784 T2 DE 69810784T2 DE 69810784 T DE69810784 T DE 69810784T DE 69810784 T DE69810784 T DE 69810784T DE 69810784 T2 DE69810784 T2 DE 69810784T2
- Authority
- DE
- Germany
- Prior art keywords
- muscle
- xanthophylles
- diseases
- treatment
- improvement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703191A SE512531C2 (sv) | 1997-09-04 | 1997-09-04 | Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur |
PCT/SE1998/001526 WO1999011251A1 (en) | 1997-09-04 | 1998-08-26 | Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69810784D1 DE69810784D1 (de) | 2003-02-20 |
DE69810784T2 true DE69810784T2 (de) | 2003-11-13 |
Family
ID=20408142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69810784T Expired - Lifetime DE69810784T2 (de) | 1997-09-04 | 1998-08-26 | Verwendung von xanthophyllen zur herstellung von arzneimitteln zur verbesserung der muskel-funktionsdauer oder zur behandlung von muskelstörungen oder erkrankungen |
Country Status (13)
Country | Link |
---|---|
US (1) | US6245818B1 (de) |
EP (1) | EP1011653B1 (de) |
JP (1) | JP3660244B2 (de) |
AT (1) | ATE230985T1 (de) |
AU (1) | AU727349B2 (de) |
CA (1) | CA2299366C (de) |
DE (1) | DE69810784T2 (de) |
DK (1) | DK1011653T3 (de) |
ES (1) | ES2191329T3 (de) |
NO (1) | NO20001087L (de) |
PL (1) | PL338982A1 (de) |
SE (1) | SE512531C2 (de) |
WO (1) | WO1999011251A1 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0001071D0 (sv) * | 2000-03-27 | 2000-03-27 | Astacarotene Ab | Method of inhibiting the expression of inflammatory cytokines and chemokines |
US7078040B2 (en) | 2000-03-27 | 2006-07-18 | Fuji Chemical Industry Co., Ltd. | Method of inhibiting the expression of inflammatory cytokines and chemokines |
US6900324B2 (en) | 2000-09-07 | 2005-05-31 | Astrazeneca Ab | Process for preparing a substituted imidazopyridine compound |
SE0003186D0 (sv) * | 2000-09-07 | 2000-09-07 | Astrazeneca Ab | New process |
US20050059659A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for controlling C-reactive protein levels |
US7723327B2 (en) | 2002-07-29 | 2010-05-25 | Cardax Pharmaceuticals, Inc. | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
US20050049248A1 (en) * | 2002-07-29 | 2005-03-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for controlling C-reactive protein levels |
US7345091B2 (en) | 2002-07-29 | 2008-03-18 | Cardax Pharmaceuticals, Inc. | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050059635A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling C-reactive protein levels |
US7320997B2 (en) | 2002-07-29 | 2008-01-22 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
AU2003256982A1 (en) * | 2002-07-29 | 2004-02-16 | Cardax Pharmaceuticals, Inc. | Structural carotenoid analogs for the inhibition and amelioration of disease |
US20050143475A1 (en) * | 2002-07-29 | 2005-06-30 | Lockwood Samuel F. | Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
US20050026874A1 (en) * | 2002-07-29 | 2005-02-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease |
US20050148517A1 (en) * | 2002-07-29 | 2005-07-07 | Lockwood Samuel F. | Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
US7375133B2 (en) * | 2002-07-29 | 2008-05-20 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US7521584B2 (en) * | 2002-07-29 | 2009-04-21 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of disease |
US20050004235A1 (en) * | 2002-07-29 | 2005-01-06 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease |
US7763649B2 (en) | 2002-07-29 | 2010-07-27 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for controlling connexin 43 expression |
WO2004021798A1 (es) * | 2002-09-03 | 2004-03-18 | Centro De Investigacion En Alimentacion Y Desarrollo A.C. | Metodo de preparacion de microcapsulas de astaxantina en quitosano y producto obtenido |
US8034372B2 (en) * | 2003-03-05 | 2011-10-11 | Nestec, Ltd. | Dietary supplement for athletic pets |
US7727752B2 (en) | 2003-07-29 | 2010-06-01 | Life Technologies Corporation | Kinase and phosphatase assays |
CN1874772A (zh) * | 2003-11-03 | 2006-12-06 | 阿斯利康(瑞典)有限公司 | 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物 |
SE0303451D0 (sv) * | 2003-12-18 | 2003-12-18 | Astrazeneca Ab | New compounds |
ES2587652T3 (es) * | 2004-02-04 | 2016-10-26 | Fuji Chemical Industry Co., Ltd. | Astaxantina para mejorar la atrofia muscular |
WO2005102356A1 (en) | 2004-04-14 | 2005-11-03 | Hawaii Biotech, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
US20060058269A1 (en) * | 2004-04-14 | 2006-03-16 | Lockwood Samuel F | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
US20060155150A1 (en) * | 2004-10-01 | 2006-07-13 | Lockwood Samuel F | Methods for the synthesis of lutein |
JP5196708B2 (ja) * | 2005-02-04 | 2013-05-15 | 富士化学工業株式会社 | アスタキサンチン及び/又はそのエステルを有効成分とする筋萎縮改善剤及び飲食物 |
EP1874289A2 (de) | 2005-03-29 | 2008-01-09 | Cardax Pharmaceuticals, Inc. | Verringerung der komplement-aktivierung und entzündung bei gewebeverletzungen durch carotenoide, carotenoid-analoga oder ihre derivate |
JP2010270095A (ja) * | 2008-05-30 | 2010-12-02 | Yamaha Motor Co Ltd | 認知行動能力向上剤 |
US10867701B1 (en) | 2010-06-28 | 2020-12-15 | Heinrich Anhold | System and method for optimizing patient-specific intervention strategies using point of care diagnostics |
JP5924592B2 (ja) * | 2013-04-30 | 2016-05-25 | 株式会社ダイセル | 抗疲労用組成物 |
CN112057420A (zh) * | 2020-09-21 | 2020-12-11 | 中国科学院烟台海岸带研究所 | 一种虾青素喷剂及其制备方法、使用方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2558372B1 (fr) * | 1984-01-25 | 1987-08-07 | Oreal | Composition medicamenteuse pour le traitement de l'acne |
JP2619491B2 (ja) * | 1988-08-11 | 1997-06-11 | サントリー株式会社 | アスタキサンチン含有組成物 |
JPH0665033A (ja) | 1992-08-11 | 1994-03-08 | Lion Corp | 口腔用組成物 |
IL110139A0 (en) | 1993-06-28 | 1994-10-07 | Howard Foundation | Pharmaceutically-active antioxidants |
WO1996023489A2 (de) * | 1995-02-03 | 1996-08-08 | Basf Aktiengesellschaft | Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen |
JPH09124470A (ja) * | 1995-10-26 | 1997-05-13 | Suntory Ltd | 抗ストレス組成物 |
-
1997
- 1997-09-04 SE SE9703191A patent/SE512531C2/sv not_active IP Right Cessation
-
1998
- 1998-08-26 JP JP2000508354A patent/JP3660244B2/ja not_active Expired - Lifetime
- 1998-08-26 PL PL98338982A patent/PL338982A1/xx unknown
- 1998-08-26 DK DK98943128T patent/DK1011653T3/da active
- 1998-08-26 ES ES98943128T patent/ES2191329T3/es not_active Expired - Lifetime
- 1998-08-26 EP EP98943128A patent/EP1011653B1/de not_active Expired - Lifetime
- 1998-08-26 CA CA002299366A patent/CA2299366C/en not_active Expired - Lifetime
- 1998-08-26 WO PCT/SE1998/001526 patent/WO1999011251A1/en active IP Right Grant
- 1998-08-26 US US09/485,704 patent/US6245818B1/en not_active Expired - Lifetime
- 1998-08-26 DE DE69810784T patent/DE69810784T2/de not_active Expired - Lifetime
- 1998-08-26 AT AT98943128T patent/ATE230985T1/de not_active IP Right Cessation
- 1998-08-26 AU AU90989/98A patent/AU727349B2/en not_active Ceased
-
2000
- 2000-03-02 NO NO20001087A patent/NO20001087L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2299366A1 (en) | 1999-03-11 |
JP3660244B2 (ja) | 2005-06-15 |
EP1011653B1 (de) | 2003-01-15 |
SE9703191L (sv) | 1999-03-05 |
NO20001087D0 (no) | 2000-03-02 |
JP2001514215A (ja) | 2001-09-11 |
ATE230985T1 (de) | 2003-02-15 |
AU727349B2 (en) | 2000-12-14 |
CA2299366C (en) | 2008-04-22 |
AU9098998A (en) | 1999-03-22 |
PL338982A1 (en) | 2000-12-04 |
DK1011653T3 (da) | 2003-05-26 |
SE512531C2 (sv) | 2000-03-27 |
US6245818B1 (en) | 2001-06-12 |
DE69810784D1 (de) | 2003-02-20 |
NO20001087L (no) | 2000-03-02 |
WO1999011251A1 (en) | 1999-03-11 |
ES2191329T3 (es) | 2003-09-01 |
EP1011653A1 (de) | 2000-06-28 |
SE9703191D0 (sv) | 1997-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69810784T2 (de) | Verwendung von xanthophyllen zur herstellung von arzneimitteln zur verbesserung der muskel-funktionsdauer oder zur behandlung von muskelstörungen oder erkrankungen | |
SE9401406L (sv) | Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma | |
ATE515265T1 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
IL99754A0 (en) | Pharmaceutical composition for treatment of autoimmune diseases containing an autoantigen or a fragment or analogue thereof | |
DE69331605D1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
BG102733A (en) | New substituted cyclic amino acids as pharmaceutical forms | |
DE69735581D1 (de) | Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung | |
IS4516A (is) | Nýtt lyfjaform | |
ATE263571T1 (de) | Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen | |
ATE234602T1 (de) | Verabreichungsform zur abgabe von steigenden wirkstoffdosen | |
ATE249828T1 (de) | Verwendung von isatin- und oxindolderivaten zur herstellung von arzeneimittel für die behandlung von mykobakteriellen erkrankungen | |
NO890186L (no) | Fremgangsmaate for fremstilling av en avgivelses- og/ellerdoseringsform for legemiddelaktive stoffer. | |
EP0214254A1 (de) | Melatoninhaltige mittel sowie deren verwendungen. | |
ATE265851T1 (de) | Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden | |
DE3781054D1 (de) | Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen. | |
BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
ATE259223T1 (de) | Pharmazeutische zusammensetzung die einen no donor enthält und dessen therapeutische anwendung | |
DE60002552D1 (de) | Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen | |
CA2405265A1 (en) | Method of preventing or treating diabetes | |
Balunov et al. | The experience in the use of piracetam in patients with consequences of stroke. | |
ATE238780T1 (de) | Verwendung von nk1-rezeptor antagonisten zur zubereitung von arzneimitteln mit kardioregulierender wirkung | |
RU96110465A (ru) | Способ сокращения сроков лечения | |
ATE301998T1 (de) | Verwendung von isovaleryl-l-carnitin zur herstellung eines arzneimittels zur vorbeugung und therapie von osteoporose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: BIOPROCESS SWEDEN AB, GUSTAVSBERG, SE |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: HOFFMANN E EITLE, 81925 MUENCHEN |
|
8364 | No opposition during term of opposition | ||
R008 | Case pending at federal patent court |
Ref document number: 1011653 Country of ref document: EP |
|
R039 | Revocation action filed |
Ref document number: 1011653 Country of ref document: EP Effective date: 20110907 |
|
R082 | Change of representative |
Ref document number: 1011653 Country of ref document: EP Representative=s name: ZACCO DR. PETERS UND PARTNER, 28359 BREMEN, DE |